Similar users

Kenneth L Londoner

Kenneth L Londoner

Signal Processing,  Atrial Fibrillation,  Medical Devices

Radoslaw Lenarczyk

Cardiology,  Clinical Trials,  Sudden Cardiac Death,  Atrial Fibrillation,  Cardiac Pacing,  Catheter Ablation,  Cardiac Electrophysiology,  Arrhythmias,  Cardiac Resynchronisation
1 publication
António Marques Pinto

António Marques Pinto

Medicine,  Operations Research,  Health Policy,  Health Economics,  Hospital Management,  Healthcare Management,  Hospital Administration
8 publications
Dr David Gerber

Dr David Gerber

Medicine,  Gynaecology,  Plastic Surgery
World Journal of Case Reports and Clinical Images

World Journal of Case Reports and Clinical Images

Clinical Cases,  Medical Case Reports,  Clinical Case Reports,  Case Sr
Ken Londoner

Ken Londoner

CEO at BioSig Technologies

Disciplines: Medicine Biology & Biochemistry Health


Ken Londoner is a researcher in the field of bioelectronic medicine. He is exploring the field’s applications across a variety of disease areas and disciplines, including neurology, auto-immune diseases, diabetes, arthritis, hypertension, pain management, cancer, and others.

Ken Londoner founded the privately held medical technology company BioSig Technologies in 2009. The company works on researching and developing a new system that would treat more accurately patients suffering from Atrial Fibrillation and Complex Arrhythmia.

Additionally, Londoner is also associated with Endicott Management Partners, another private investment company focused on medical technology and consumer-related companies, where he serves as Managing Partner. Prior to this, he served as Co-Founder and Member of Board of Directors at Safe Ports.
He studied at Lafayette College in Easton, Pennsylvania and holds a degree in economics and finance. He also earned his MBA from NYU’s Stern School of Business with a dual major in finance and management.

Published articles Show More


CEO Since 2009

BioSig Technologies (San Francisco US)

BioSig is working to develop and deliver the advanced signal processing solutions that will unlock the future of bioelectronic medicine, starting with the PURE EP™ System.

Ken Londoner built BioSig to achieve this vision – with a strong commitment to research, a world-class leadership team, and a network of expert partners.

BioSig is now achieving important milestones as it prepares to enter the fast-growing electrophysiology market, but its aspirations reach even further: to lead one of the most innovative and most promising frontiers in healthcare.


Economics and Finance 1985 - 1989

Lafayette College (San Francisco US)

Bachelor's Degree in Economics and Finance


Electrophysiology Bioelectronic Medicine

Contact me

Report this profile